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CASE REPORT
INTRODUCTION
Fever of unknown origin is a condition where a
patient suffers from continuous fever for 3 weeks with
a temperature of over 38.3°C with an uncertain cause
even after one week of intensive laboratory and other
medical investigation.1,2,3
Other terms used for this condition include febris et
causa ignota, fever of obscure origin, fever of
undetermined origin, unexplained fever, prolonged fever,
pyrexia of unknown origin, and fever of unknown origin
(FUO). The cause of FUO according to the type of
illness is classified into the following six groups:1,2
1. Infection (45-55%)
Important infectious causes of FUO include
tuberculosis, sepsis, systemic bacterial infections (such
as salmonellosis and brucellosis), Bacterial
endocarditis, mononucleosis, toxoplasmosis and
fungal disease.
2. Neoplasm (12-20%)
Important neoplastic causes of FUO include
Hodgkin’s and non-Hodgkin’s diseases, Leukemia,
histiocytosis (particularly in children), Renal cell
carcinoma and Hepatoma.
3. Collagen disease (10-15%)
FUO may be caused by Sarcoidosis, Polyarthritis
nodosa, Wegener’s granulomatosis, Juvenile
Rheumatoid Arthritis and dermatomyocitis.
4. Hypersensitivity disorder
FUO due to hypersensitivity is chiefly a reaction to
drugs such as sulphonamide, penicillin, rifampicin,
isoniazid, phenytoin, or methyldopa.
5. Metabolic disorder
Important metabolic causes of FUO are porphyria
metabolic disorder, polyserocytis (Familial
Mediterranean Fever) and Type V
hypertriglyceridemia.
6. Factitious Fever
Examinations such as blood test, microbiological  cul-
ture from body fluids/surface lesions, seroimmunological
testing, or routine x-ray could be used prior to resorting to
available advanced examination modalities such as the
ultrasound, endoscopy, or CT-scan/MRI.4
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ABSTRACT
Infection, especially extra pulmonary tuberculosis, remain the leading cause of fever of unknown origin
(FUO). FUO is defined as temperature higher than 38.3 ºC with duration of fever of more than 3 weeks. We
reported a case of liver tuberculosis, whose had fever more than 38.3 ºC in 2 months. A liver biopsy and
histology evaluation have performed revealing liver tuberculosis. The patient received oral anti-tuberculosis
agents. But after three days of anti-tuberculosis treatment, the patient experience jaundice. The patient was
diagnosed as a drug induced hepatitis. After adjusted regimen of oral anti-tuberculosis, the patient’s
condition improved. The patient was back home with good conditions.
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At the next phase, consider making a closer
diagnosis through biopsy of suspected sites.
Examinations such as angiography, aortography, or
lymphangiography could also be performed.
Serological testing is actually very beneficial for
patients with FUO.1 Two blood specimens are usually
required for the test. Efforts should be made to ensure
the availability of the two specimens to facilitate the
interpretation of the serological titer results. A titer
increase of four times or more has a very significant
meaning to determine the possible cause of disease. It is
important to master the art of interpretation, since
results may not be as apparent.
Isolation of the microorganism causing the disease is
the chief diagnostic criteria in patients suspected of
infectious fever. A common examination is blood, urine,
and stool culture as well as viral isolation.1
With the wider spectrum of viral disease and the
influence of urbanization, globalization as well as
inadequate environment, there is a greater possibility of
patients suffering from viral infection. At this moment,
there needs to be guidelines to differentiate a patient
with viral or bacterial disease, which entail a totally
different treatment approach. An examination that could
be performed at the initial phase is hematological
evaluation, where acute bacterial infection would
produce a shift to the left, with or without leukocytosis.
If such condition is not found and we still need to
differentiate viral and bacterial infection, C-reactive
protein (CRP) may be examined. CRP may increase
over tenfolds in acute bacterial infection.1,4
X-ray photo is a vital medical examination modality,
particularly for diagnosing renal and pulmonary
disorders. The bone marrow and joints are also ideal
sites for x-ray evaluation.1,4
Biopsy plays a great role in determining the cause of
FUO, and could be performed where modern medical
support facilities are unavailable. It is important for the
diagnosis of diseases such as lymphoma, malignant
metastasis, tuberculosis, or fungal infection, particularly
in enlarged glands.1,4
Considering the fact that the ultrasound is very easy
to use, the association between a disorder in the field of
internal medicine, it use has increased and is more
widespread, particularly for evaluation of the heart or
abdomen. This examination method is especially useful
for conditions such as atrial myxoma or vegetations on
the heart valves.
Abdominal ultrasound can detect disorders in the liver,
kidneys, retroperitoneal space, and pelvis. Bear in mind
that false positives may be obtained, and ultrasound
should always be considered a supportive examination,
taking into consideration the totality of the disease.1,4
In the future, CT-scan is expected to greatly
facilitate diagnosis, by demonstrating body
abnormalities through horizontal sections of body organ
anatomy. It is the ideal examination modality to evaluate
retroperitoneal abnormalities.1
Efforts to treat undiagnosed fever with adjuvant
therapy, and is only justified when all methods to achieve
diagnostic certainty has been attempted.1,5 The principle
is that drugs should be used with the proper indication
according to local knowledge and should be specific in
nature.
CASE REPORT
Mrs. R, 42 years, was admitted to Cipto
Mangunkusumo General Hospital with a chief complaint
of fever since 2 months prior to admission. The fever
was fluctuating, and was sometimes accompanied by
chills in the mornings or afternoons. There was no cough
or running nose. The fever responded to medication but
would reemerge after the medication wears out. The
patient had a loss of appetite.
Six weeks prior to admission at Cipto Mangunkusumo
General Hospital, the patient had been admitted to
another hospital for 6 weeks. During 1 week of
hospitalization, the patient’s fever dropped and then rose,
never to fall again. At other hospital, the patient had
undergone a series of examination, with results as
follows:  normal chest x-ray; ultrasound revealing a
normal liver and bile duct, a slightly enlarged spleen, and
no enlargement of paraaortic lymph nodes. The patient
had also undergone blood testing for malaria and widal,
both turning out negative. C3, C4, and DsDNA testing
also came out normal.
There was no problem urinating or with bowel
movements. Because the patient felt no improvement,
she came to Cipto Mangunkusumo General National
Hospital.
Prior history revealed no history of jaundice, heart
disease or epigastric pain.
From physical examination at admission we found
the following: the patient was moderately ill, fully
conscious, with a blood pressure of 110/70 mmHg, pulse
rate of 110 x/minute, body temperature of 38°C, and
respiratory rate of 28 x/minute. Her conjunctiva were
pale, her sclera not jaundiced. Her jugular venous
pressure was 5 – 2 cm H2O. Heart evaluation revealed
normal first and second heart sounds without murmur or
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gallop. Lung examination demonstrated a vesicular
breath sound without rales or wheezing.
Abdominal evaluation results were as follows: the
abdomen was flat, not distended, without tenderness.
The heart and spleen were not palpable. The
extremities were warm and not edematous.
The results of laboratory examination during
admission were as follows: Hemoglobin level 5.5 g%,
white blood cell count 3800/ml, platelet count 150,000/
ml, ureum level 13 mg/dl, creatinine level 0.9 mg/dl,
sodium level 130 meq/l, potassium level 3.6 meq/l, SGOT
= 39 U/l, SGPT = 35  U/l. HIV testing was negative and
there was no signs of fungus in the patient’s blood.
On the seventh day, bone marrow puncture was
performed, revealing histoplasma. The diagnosis was thus
histoplasmosis. The patient was immediately scheduled
to take Amphoterycin B according to hospital protocol,
which is as follows:
• Day 1, administration of a test dose of 5 mg of
Amphoterycin B
• Day 2, administration of  10 mg of Amphoterycin B
• Day 3, administration of  15 mg of Amphoterycin B
• Day 4, administration of  20 mg of Amphoterycin B
• Day 5, administration of  25 mg of Amphoterycin B
• And so on.
Note that Amphoterycin B was added to 500 cc of
5% Dextrose to be administered within 6 hours, and that
1 vial of Dexamethasone and 1 tablet of Paracetamol
was administered prior to that.
After the seventh day of Amphoterycin B
administration, the patient was still feverish with a body
temperature of 38-41°C. Amphoterycin B was still
administered, suspecting that the patient suffered from
histoplasmosis that had not responded to treatment.
On the 12th day of treatment with Amphoterycin B,
the patient and family refused to continue treatment,
signing a refusal letter. Since the patient needed
treatment, she was given 2 x 200 mg of Itraconazole
(Sporanox).
On the 37th day, the patient underwent a repeat
abdominal ultrasound as a preparation for biopsy, since
hepatosplenomegaly was found during physical
examination. Ultrasound revealed hepatosplenomegaly
and enlarged paraaortic and hepatic parahilar lymph
nodes. The patient immediately underwent liver biopsy.
There was a suspicion that the prolonged fever in
this patient might be due to tuberculosis. A Mantoux test
was thus performed for screening, and a repeat chest
x-ray taken. The Mantoux test revealed negative
findings, while the chest x-ray was normal.
On the 42nd day of hospitalization, the liver biopsy
pathology evaluation revealed liver tuberculosis with
casseation.
On the 43rd day of treatment, the patient received the
following oral anti-tuberculosis drugs: rifampisin 1 x 450
mg, INH 1 x 300 mg, Pirazinamid 3 x 500 mg, Etambutol
2 x 250 mg dan Vit B6  3 x 10 mg. Her fever fell to
37.5°C.
On the 45th day of hospitalization, which was the third
day of anti-tuberculosis treatment, the patient’s sclera
became jaundiced. The patient’s SGOT and SGPT were
then examined, turning out to be 182 U/l and 157 U/l
respectively.
Oral anti-tuberculosis was continued, with the
following regimen:
• Ethambutol 2 x 250 mg
• Streptomycin 1 x 750 mg
• Ofloxacin 1 x 400 mg
The patient was scheduled for a rifampycin trial, but
the test was not performed due to financial constraints.
Repeat ultrasound examination did not find signs of
obstruction.
On the 45th day, the subdivision of Hepatology agreed
to continue oral anti-tuberculosis agents with SGOT,
SGPT, and billirubin monitoring twice weekly. If the
patient’s condition improves, the previous drugs may be
reused with the smallest most effective dose.
On the 65th day of treatment, the patient was released
free of fever and in a better condition. Treatment with
Isoniazid was reestablished gradually, starting with a dose
of 1 x 100 mg for 3 days then increased to 2 x 100 mg,
while all other treatments continued as usual.
Rifampycin was no longer administered to this
patient.
DISCUSSION
At the time of admission into Cipto Mangunkusumo
General Hospital, the patient was diagnosed with
prolonged fever, since she has had a fever since 2 months
prior to admission and had undergone various
examinations with normal result. This is in accordance
with the definition stated in various literature.1,2,3
Various causes of fever has been eliminated from
laboratory examinations, such as negative Widal test
results, negative malaria test results, negative HIV test
results, a normal chest x-ray, and a generally normal
ultrasound finding.
Since the examinations had not provided optimal
results, a bone marrow puncture was performed, firstly
suggesting chronic granulomatous leukemia. Since there
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was no leukocytosis in the patient’s peripheral blood and
histoplasm was found, the diagnosis was histoplasmosis.
The patient immediately received treatment for
histoplasmosis with Amphoterycin B, which was in
accordance with literature stating Amphoterycin B as
the drug of choice for histoplasmosis.6,7
After administration of Amphoterycin B for 12 days
according to protocol, the patient remained feverish. Due
to the lack of improvement, a repeat chest x-ray and a
Mantoux test were performed to find possible cryptic
tuberculosis. The chest x-ray turned out normal, and the
Mantoux test negative.
The patient then underwent a repeat abdominal
ultrasound, revealing hepatosplenomegaly and enlarged
paraaortic lymph nodes. A liver biopsy and
histopathology evaluation were then performed,
revealing liver tuberculosis. The patient immediately
received the following oral anti-tuberculosis agents:
• Rifampycin 1 x 450 mg,
• Isoniazid 1 x 300 mg,
• Pyrazinamid 3 x 500 mg,
• Ethambutol 2 x 250 mg, and
• Vitamin B6 3 x 10 mg.
After three days of anti-tuberculosis treatment, the
patient’s eyes became jaundiced, and liver function
testing revealed an SGOT of 182 U/l and SGPT of 157
U/l. The patient was thus suspected to have suffered
drug-induced hepatitis.
Oral anti-tuberculosis agents were still administered
with an adjusted dose, where rifampycin was replaced
with streptomycin. The following regimen was thus
administered: 1 x 750 mg of Streptomycin, 2 x 250 mg of
Ethambutol, 1 x 400 mg of Ofloxacyn. Isoniazid was
temporarily terminated. This was in accordance with
literature, stating that oral anti-tuberculosis agents are the
choice treatment for hepatic tuberculosis.8,9  Literature
also states that rifampycin could disturb liver function.10
With an adjusted regimen of oral anti-tuberculosis,
the patient’s condition improved, the fever subsided, and
the patient’s eyes were no longer jaundiced.
From abdominal ultrasound on the 13th of September
2001 at Cipto Mangunkusumo Hospital, it was concluded
that the patient suffered from hepatosplenomegaly and
enlarged paraaortic and parahillar hepatic lymph nodes.
The results of histopathology evaluation of the patient’s
liver biopsy were as follows: numerous granulomatous
lesions were found, a large one demonstrating caseous
necrosis, epitheloid cells, and 1-2 Langhan datia cells.
The findings were found to be in accordance with liver
tuberculosis with casseation.
Figure 1. Histology Evaluation from Liver Biopsy Show
Numerous Granulomatous Lesions, Epitheloid Cells and
Langhan Datia Cells.
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